Major Improvements in Psoriatic Arthritis Disease Activity Achieved With Methotrexate
Methotrexate with targeted escalation resulted in significant improvement in the skin, joint, dactylitis, enthesitis, and functional domains of PsA.
Spondyloarthitis
Working Group Endorses Patient-Reported Outcome Measure for PsA-Related Quality of Life
The Psoriatic Arthritis Impact of Disease questionnaire was endorsed as a core outcome measure for psoriatic arthritis-specific health-related quality of life.
Inflammatory Arthritis and the Gut Microbiome: Do Microbes Hold the Key to New Treatments?
Recent research points to an association between the gut microbiome composition and various types of immune-mediated inflammatory arthritides.
Inflammatory Back Pain and Neuropathic Pain May Affect Axial Spondyloarthritis Outcomes
Patients with axial spondyloarthritis who have inflammatory back pain or neuropathic pain may have higher pain intensity, pain interference, disease activity, and greater functional limitation compared with individuals with axial spondyloarthritis but without either comorbidity.
Next post in Spondyloarthritis
